Thursday, June 11

Browsing: OSPFS

Survivors

Izalontamab Brengitecan Improves OS/PFS in Advanced/Metastatic TNBC

By NewsCancerJune 2, 20260

Findings from the phase 3 PANKU-Breast02 trial (NCT06382142) presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting…

► Necessary Cookies Always Active

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

► Functional Cookies Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

► Analytical Cookies Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

► Advertisement Cookies Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.